Slide 1James W. Cooper, RPh,PhD, BCPS, CGP, FASCP, FASHP, FCP, Emeritus Professor of Pharmacy, UGa and Consultant Pharmacist NOTE: Dr.J. Russell May of GHSU and UGa Clinical…
Slide 1Hypertriglyceridemia and Cardiovascular Disease Management: The Role of Omega-3 Fatty Acids Ronald A. Codario, MD Assistant Clinical Professor of Medicine University…
Slide 1 Diabetes and Cardiovascular Risk La lezione dai grandi studi di intervento Slide 2 Rischio di eventi cardiovascolari a 8 anni nel diabete (Framingham Study) Slide…
Associations between periodontitis and CHD/stroke – how strong is the evidence Thomas Dietrich Boston University School of Dental Medicine “old news” 1997 Associated…
Slide 1 University of Khartoum Master of Clinical pharmacy Batch 8 Lipid Lowering Drugs Presented by: Ameera M. H. Algezouli Yasmin H. Elbadawi 1 Pathophysiology(lipid &lipoprotein…
1. Primary prevention : From Theory to real clinical evidence (insights from Jupiter trial) Lobna Farag Eltoony Head of diabetes and Endocrinology Unit Department Of Internal…
NCEP ATP IV Guidelines: Whatâs New in 2012? NCEP ATP IV GuidelineS: 2013 Update The National Cholesterol Education Program Adult Treatment Panel guidelines, national guidelines…
Slide 1Statins and CAD Prevention: Rosuvastatin Slide 2 Rising burden of CVD in India (2005) Lancet 2005;366:1744-9 Estimated proportions of total deaths and DALYs lost by…